ID   PRAX_RAT                Reviewed;        1383 AA.
AC   Q63425;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2002, sequence version 2.
DT   24-JUL-2024, entry version 145.
DE   RecName: Full=Periaxin {ECO:0000303|PubMed:8155317};
GN   Name=Prx;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Wistar;
RX   PubMed=8155317; DOI=10.1016/0896-6273(94)90208-9;
RA   Gillespie C.S., Sherman D.L., Blair G.E., Brophy P.J.;
RT   "Periaxin, a novel protein of myelinating Schwann cells with a possible
RT   role in axonal ensheathment.";
RL   Neuron 12:497-508(1994).
RN   [2]
RP   SEQUENCE REVISION TO 1364-1371.
RA   Brophy P.J.;
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=9488714; DOI=10.1074/jbc.273.10.5794;
RA   Dytrych L., Sherman D.L., Gillespie C.S., Brophy P.J.;
RT   "Two PDZ domain proteins encoded by the murine periaxin gene are the result
RT   of alternative intron retention and are differentially targeted in Schwann
RT   cells.";
RL   J. Biol. Chem. 273:5794-5800(1998).
RN   [4]
RP   PROTEIN SEQUENCE OF 1019-1033, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RA   Lubec G., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [5]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DOMAIN.
RX   PubMed=10671475; DOI=10.1074/jbc.275.7.4537;
RA   Sherman D.L., Brophy P.J.;
RT   "A tripartite nuclear localization signal in the PDZ-domain protein L-
RT   periaxin.";
RL   J. Biol. Chem. 275:4537-4540(2000).
RN   [6]
RP   INTERACTION WITH DRP2, SUBUNIT, TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=11430802; DOI=10.1016/s0896-6273(01)00327-0;
RA   Sherman D.L., Fabrizi C., Gillespie C.S., Brophy P.J.;
RT   "Specific disruption of a Schwann cell dystrophin-related protein complex
RT   in a demyelinating neuropathy.";
RL   Neuron 30:677-687(2001).
RN   [7]
RP   INTERACTION WITH SCN10A, AND IDENTIFICATION IN A COMPLEX WITH SCN10A.
RX   PubMed=12591166; DOI=10.1016/s0169-328x(02)00661-7;
RA   Malik-Hall M., Poon W.-Y.L., Baker M.D., Wood J.N., Okuse K.;
RT   "Sensory neuron proteins interact with the intracellular domains of sodium
RT   channel NaV1.8.";
RL   Brain Res. Mol. Brain Res. 110:298-304(2003).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; SER-133; SER-243; SER-838;
RP   SER-1020; SER-1323; SER-1329 AND SER-1361, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Scaffolding protein that functions as part of a dystroglycan
CC       complex in Schwann cells, and as part of EZR and AHNAK-containing
CC       complexes in eye lens fiber cells. Required for the maintenance of the
CC       peripheral myelin sheath that is essential for normal transmission of
CC       nerve impulses and normal perception of sensory stimuli. Required for
CC       normal transport of MBP mRNA from the perinuclear to the paranodal
CC       regions. Required for normal remyelination after nerve injury. Required
CC       for normal elongation of Schwann cells and normal length of the
CC       internodes between the nodes of Ranvier. The demyelinated nodes of
CC       Ranvier permit saltatory transmission of nerve impulses; shorter
CC       internodes cause slower transmission of nerve impulses. Required for
CC       the formation of appositions between the abaxonal surface of the myelin
CC       sheath and the Schwann cell plasma membrane; the Schwann cell cytoplasm
CC       is restricted to regions between these appositions. Required for the
CC       formation of Cajal bands and of Schmidt-Lanterman incisures that
CC       correspond to short, cytoplasm-filled regions on myelinated nerves.
CC       Recruits DRP2 to the Schwann cell plasma membrane. Required for normal
CC       protein composition of the eye lens fiber cell plasma membrane and
CC       normal eye lens fiber cell morphology. {ECO:0000250|UniProtKB:O55103}.
CC   -!- SUBUNIT: Homodimer (via PDZ domain) (PubMed:11430802). Interacts with
CC       SCN10A. Found in a complex with SCN10A (PubMed:12591166). Interacts
CC       with DRP2 (PubMed:11430802). Identified in a dystroglycan complex that
CC       contains at least PRX, DRP2, UTRN, DMD and DAG1 (By similarity).
CC       Detected in a complex composed of at least EZR, AHNAK, PPL and PRX (By
CC       similarity). Identified in a complex with EZR, AHNAK, BFSP1, BFSP2,
CC       ANK2, PLEC, VIM and spectrin (By similarity).
CC       {ECO:0000250|UniProtKB:E1BM58, ECO:0000250|UniProtKB:O55103,
CC       ECO:0000250|UniProtKB:Q9BXM0, ECO:0000269|PubMed:11430802,
CC       ECO:0000269|PubMed:12591166}.
CC   -!- INTERACTION:
CC       Q63425; Q62968: Scn10a; NbExp=2; IntAct=EBI-1800492, EBI-1800320;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Nucleus
CC       {ECO:0000269|PubMed:10671475}. Cytoplasm {ECO:0000269|PubMed:10671475,
CC       ECO:0000269|PubMed:8155317}. Cell membrane
CC       {ECO:0000269|PubMed:10671475, ECO:0000269|PubMed:11430802,
CC       ECO:0000269|PubMed:8155317}; Peripheral membrane protein {ECO:0000305};
CC       Cytoplasmic side {ECO:0000305}. Note=Detected in the Schwann cell
CC       nucleus prior to the onset of myelination (By similarity). Detected in
CC       Schwann cells at periaxonal myelin membranes (PubMed:10671475,
CC       PubMed:11430802, PubMed:8155317). Associated with the cell membrane
CC       during myelination (By similarity). {ECO:0000250|UniProtKB:O55103,
CC       ECO:0000269|PubMed:10671475, ECO:0000269|PubMed:11430802,
CC       ECO:0000269|PubMed:8155317}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm
CC       {ECO:0000250|UniProtKB:O55103}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:O55103}.
CC       Cell junction {ECO:0000250|UniProtKB:O55103}. Note=Colocalizes with
CC       ACTB at tricellular junctions between eye lens fiber cells.
CC       {ECO:0000250|UniProtKB:O55103}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=L-periaxin;
CC         IsoId=Q63425-1; Sequence=Displayed;
CC       Name=2; Synonyms=S-periaxin;
CC         IsoId=Q63425-2; Sequence=VSP_004368, VSP_004369;
CC   -!- TISSUE SPECIFICITY: Detected in sciatic nerve and in trigeminal nerve
CC       Schwann cells (PubMed:11430802). Detected in myelinating Schwann cells
CC       in sciatic nerve (at protein level) (PubMed:10671475, PubMed:8155317).
CC       {ECO:0000269|PubMed:10671475, ECO:0000269|PubMed:11430802,
CC       ECO:0000269|PubMed:8155317}.
CC   -!- DEVELOPMENTAL STAGE: mRNA and protein levels peak in the sciatic nerve
CC       between posnatal days 8 and 20; thereafter they decline precipitously.
CC       {ECO:0000269|PubMed:8155317}.
CC   -!- DOMAIN: Has a remarkable domain of repetitive pentameric units
CC       sometimes followed by a tripeptide spacer, it may separate two
CC       functional basic and acidic domains. {ECO:0000305}.
CC   -!- DOMAIN: The Arg/Lys-rich basic domain functions as a tripartite nuclear
CC       localization signal. {ECO:0000269|PubMed:10671475}.
CC   -!- DOMAIN: The PDZ domain contains the signal for export from the nucleus
CC       (By similarity). The N-terminal region including the PDZ domain is
CC       required for the formation of Cajal bands on myelinated nerves (By
CC       similarity). {ECO:0000250|UniProtKB:O55103,
CC       ECO:0000250|UniProtKB:Q9BXM0}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- SIMILARITY: Belongs to the periaxin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z29649; CAA82757.2; -; mRNA.
DR   PIR; I58157; I58157.
DR   RefSeq; NP_076466.2; NM_023976.2. [Q63425-1]
DR   AlphaFoldDB; Q63425; -.
DR   SMR; Q63425; -.
DR   IntAct; Q63425; 3.
DR   STRING; 10116.ENSRNOP00000024771; -.
DR   GlyGen; Q63425; 5 sites, 1 O-linked glycan (5 sites).
DR   iPTMnet; Q63425; -.
DR   PhosphoSitePlus; Q63425; -.
DR   PaxDb; 10116-ENSRNOP00000024771; -.
DR   GeneID; 78960; -.
DR   KEGG; rno:78960; -.
DR   UCSC; RGD:619960; rat. [Q63425-1]
DR   AGR; RGD:619960; -.
DR   CTD; 57716; -.
DR   RGD; 619960; Prx.
DR   eggNOG; ENOG502QS7Y; Eukaryota.
DR   InParanoid; Q63425; -.
DR   OrthoDB; 3061191at2759; -.
DR   PhylomeDB; Q63425; -.
DR   PRO; PR:Q63425; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0016607; C:nuclear speck; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0008366; P:axon ensheathment; IEP:RGD.
DR   GO; GO:0021675; P:nerve development; IEP:RGD.
DR   GO; GO:0032290; P:peripheral nervous system myelin formation; ISO:RGD.
DR   GO; GO:0032287; P:peripheral nervous system myelin maintenance; ISO:RGD.
DR   GO; GO:0043484; P:regulation of RNA splicing; IBA:GO_Central.
DR   GO; GO:0019233; P:sensory perception of pain; ISO:RGD.
DR   GO; GO:0019226; P:transmission of nerve impulse; ISO:RGD.
DR   CDD; cd00992; PDZ_signaling; 1.
DR   Gene3D; 2.30.42.10; -; 1.
DR   InterPro; IPR052082; Myelin_sheath_structural.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   PANTHER; PTHR23348:SF42; PERIAXIN; 1.
DR   PANTHER; PTHR23348; PERIAXIN/AHNAK; 1.
DR   Pfam; PF00595; PDZ; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF50156; PDZ domain-like; 1.
DR   PROSITE; PS50106; PDZ; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Cytoplasm;
KW   Direct protein sequencing; Membrane; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat.
FT   CHAIN           1..1383
FT                   /note="Periaxin"
FT                   /id="PRO_0000058565"
FT   DOMAIN          16..99
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   REPEAT          432..436
FT                   /note="1"
FT   REPEAT          440..444
FT                   /note="2"
FT   REPEAT          448..452
FT                   /note="3"
FT   REPEAT          456..460
FT                   /note="4"
FT   REPEAT          461..465
FT                   /note="5"
FT   REPEAT          466..470
FT                   /note="6"
FT   REPEAT          474..478
FT                   /note="7"
FT   REPEAT          482..486
FT                   /note="8"
FT   REPEAT          487..491
FT                   /note="9"
FT   REPEAT          492..496
FT                   /note="10"
FT   REPEAT          497..501
FT                   /note="11"
FT   REPEAT          502..506
FT                   /note="12"
FT   REPEAT          507..511
FT                   /note="13"
FT   REPEAT          515..519
FT                   /note="14"
FT   REPEAT          523..527
FT                   /note="15"
FT   REPEAT          531..535
FT                   /note="16"
FT   REPEAT          536..540
FT                   /note="17"
FT   REPEAT          544..548
FT                   /note="18"
FT   REPEAT          549..553
FT                   /note="19"
FT   REPEAT          554..558
FT                   /note="20"
FT   REPEAT          562..566
FT                   /note="21"
FT   REPEAT          567..571
FT                   /note="22"
FT   REPEAT          575..579
FT                   /note="23"
FT   REPEAT          580..584
FT                   /note="24"
FT   REPEAT          585..589
FT                   /note="25"
FT   REPEAT          593..597
FT                   /note="26"
FT   REPEAT          601..605
FT                   /note="27"
FT   REPEAT          606..610
FT                   /note="28"
FT   REPEAT          611..615
FT                   /note="29"
FT   REPEAT          619..623
FT                   /note="30"
FT   REPEAT          627..631
FT                   /note="31"
FT   REPEAT          632..636
FT                   /note="32"
FT   REPEAT          637..641
FT                   /note="33"
FT   REPEAT          645..649
FT                   /note="34"
FT   REPEAT          653..657
FT                   /note="35"
FT   REPEAT          658..662
FT                   /note="36"
FT   REPEAT          663..667
FT                   /note="37"
FT   REPEAT          671..675
FT                   /note="38"
FT   REPEAT          676..680
FT                   /note="39"
FT   REPEAT          684..688
FT                   /note="40"
FT   REPEAT          689..693
FT                   /note="41"
FT   REPEAT          694..698
FT                   /note="42"
FT   REPEAT          699..703
FT                   /note="43"
FT   REPEAT          705..709
FT                   /note="44"
FT   REPEAT          713..717
FT                   /note="45"
FT   REPEAT          718..722
FT                   /note="46"
FT   REGION          432..722
FT                   /note="46 X 5 AA approximate tandem repeats of [LVMGIE]-
FT                   [PSM]-[EDKA]-[LIVMA]-[AQKHPRT]; that may have a tripeptide
FT                   spacer of [ALKD]-[IPV]-[KPH]"
FT   REGION          1251..1383
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           70..84
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BXM0"
FT   MOD_RES         7
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         133
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         243
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         838
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         971
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O55103"
FT   MOD_RES         1020
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1271
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O55103"
FT   MOD_RES         1275
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O55103"
FT   MOD_RES         1277
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O55103"
FT   MOD_RES         1285
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O55103"
FT   MOD_RES         1323
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1329
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1361
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         128..147
FT                   /note="NIQSLSPVKKKKMVIGTLGT -> VRVLSPVPVQDSPSDAVAAP (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9488714"
FT                   /id="VSP_004368"
FT   VAR_SEQ         148..1383
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9488714"
FT                   /id="VSP_004369"
SQ   SEQUENCE   1383 AA;  146400 MW;  FF6593BCFA23A437 CRC64;
     MEARSRSAEE LRRAELVEII VETEAQTGVS GFNVAGGGKE GIFVRELRED SPAAKSLSLQ
     EGDQLLSARV FFENFKYEDA LRLLQCAEPY KVSFCLKRTV PTGDLALRPG TVSGYEMKGP
     RAKVAKLNIQ SLSPVKKKKM VIGTLGTPAD LAPVDVEFSF PKFSRLRRGL KADAVKGPVP
     AAPARRRLQL PRLRVREVAE EAQVARMAAA APPSRKAKSE AEVATGAGFT APQIELVGPR
     LPSAEVGVPK VSVPKGTPST EAASGFALHL PTLGLGAPAA PAVEPPTTGI QVPQVELPTL
     PSLPTLPTLP CLDTQEGAAV VKVPTLDVAA PSVEVDLALP GAEVEAQGEV PEVALKMPRL
     SFPRFGVRGK EATEAKVVKG SPEAKAKGPR LRMPTFGLSL LESRPSGPEV AAESKLKLPT
     LKMPSFGISV AGPEVKAPKG PEVKLPKVPE IKLPKAPEAA IPDVQLPEVQ LPKMSDMKLP
     KIPEMAVPDV HLPEVKLPKV PEMKVPEMKL PKIPEMAVPD VHLPDIQLPK VPEMKLPDMK
     LPKVPEMAVP DVHLPDIQLP KVPEMKLPDM KLPKVPEMAV PDVRIPEVQL PKVSEVKLPK
     IPDMAVPDVR LPELQLPKMS EVKLPKIPDM AVPDVRLPEV QLPKVSELKL PKVPEMTMPD
     IRLPEVQLPK VPDIKLPEIK LPKVPEMAVP DVPLPELQLP KVPQVPDVHL PKVPEMKLPK
     VPEAQRKSAG AEQAEKTEFS FKLPKMTVPK LGKVTKPGEA GIEVPDKLLI LPCLQPEVGT
     EVARVGVPSL SLPSVELDLP GALGLEGQVQ EAVSGKVEKP EGPRVAVGTG EAGFRVPSVE
     IVNPQLPTVE VKKEQLEMVE MKVKPTSKFS LPKFGLSGPK AVKAEVEGPG RATKLKVSKF
     AISLPRARAG TDADAKGAGE AGLLPALDLS IPQLSLDAQL PSGKVEVAGA ESKPKGSRFA
     LPKFGAKGRD SEADVLVAGE AELEGKGWGW DGKVKMPKLK MPSFGLSRGK EAEIQDGRVS
     PGEKLEAIAG QLKIPEVELV TPGAQETEKV TSGVKPSGLQ VSTTRQVVAE GQEGAQRVSS
     LGISLPQVEL ASFGEAGPEI AAPSAEGTVG SRIQVPQVML ELPGTQVAGG DLLVGEGIFK
     MPTVTVPQLE LDVGLGHEAQ AGETAKSEGG LKLKLPTLGA GGKGEGAEAQ SPEAQHTFHI
     SLPDVELTSP VSSHAEYQVV EGDGDGGHKL KVRLPLFGLA RAKEGIETGE KVKSPKLRLP
     RVGFSQSESA SGEGSPSPEE EEEGSGEGAS GRRGRVRVRL PRVGLASPSK GSKGQEGDAA
     SKSPVGEKSP KFRFPRVSLS PKARSGSKDR EEGGFRVRLP SVGFSETAAP GSARIEGTQA
     AAI
//
